Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 261 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2915 (91%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-05-10 | 2018-10-11 | 9939 |
| TEVA-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-09-27 | 2018-10-12 | 62458 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-09-05 | 2020-01-24 | 93172 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2020-04-23 | 2020-08-27 | 113010 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2020-09-17 | 2020-12-17 | 124468 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2018-06-15 | 2019-05-28 | 52485 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2018-06-15 | 2018-11-08 | 52488 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2018-12-04 | 2019-08-16 | 68605 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2020-03-26 | 2020-09-24 | 109635 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2020-04-02 | 2020-07-23 | 110652 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110655 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2020-08-06 | 2020-08-27 | 121855 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2021-08-27 | 2022-01-28 | 144691 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144694 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2021-12-17 | 2022-05-26 | 151433 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165430 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-07-25 | 2023-04-28 | 165433 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2022-12-15 | 2023-04-28 | 178521 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Resolved | 2024-03-07 | 2025-09-02 | 221531 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2025-01-23 | 2025-09-02 | 248430 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |